Johnson & Johnson to acquire Auris Health for $3.4 billion

Johnson & Johnson, through its subsidiary Ethicon, Inc., has entered into a definitive agreement to acquire Auris Health, Inc., a developer of robotic technologies for lung cancer, for approximately $3.4 billion in cash, with additional contingent payments of up to $2.35 billion.

“Johnson & Johnson has announced that Ethicon, Inc., entered into a definitive agreement to acquire Auris Health, Inc. for approximately $3.4 billion in cash.”accuprec.com

• 1 source
• accuprec.comJohnson & Johnson to Acquire surgical robotics firm Auris Health, Inc. for US$3.4 billion - AccuprecJul 8, 2021

Summarized from public sources; check the original articles before acting on it.